tiprankstipranks
Advertisement
Advertisement

NBIX Stock Latest News

3 Different Ways to Play the Rally in Psychedelic Stocks
Market News3 Different Ways to Play the Rally in Psychedelic Stocks
5d ago
DFTX
NBIX
Neurocrine’s Crenessity enables glucocorticoid dose reduction in CAH study
PremiumThe Fly
Neurocrine’s Crenessity enables glucocorticoid dose reduction in CAH study
7d ago
NBIX
Neurocrine Biosciences: Conservative VYKAT XR Outlook and Aggressive Margin Assumptions Justify Hold Rating
PremiumRatings
Neurocrine Biosciences: Conservative VYKAT XR Outlook and Aggressive Margin Assumptions Justify Hold Rating
8d ago
NBIX
Wells Fargo downgrades Soleno on pending acquisition
PremiumThe Fly
Wells Fargo downgrades Soleno on pending acquisition
12d ago
NBIX
SLNO
Neurocrine to present new real-world evidence of Ingrezza use in patients
PremiumThe Fly
Neurocrine to present new real-world evidence of Ingrezza use in patients
15d ago
NBIX
Neurocrine price target lowered to $176 from $177 at RBC Capital
PremiumThe FlyNeurocrine price target lowered to $176 from $177 at RBC Capital
22d ago
NBIX
3 Best Trending Stocks, According to Analysts – 4/7/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
22d ago
AMGN
NBIX
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
Premium
The Fly
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
22d ago
ARM
WAL
Neurocrine price target raised to $166 from $151 at Wedbush
PremiumThe Fly
Neurocrine price target raised to $166 from $151 at Wedbush
22d ago
NBIX
SLNO
Neurocrine price target raised to $199 from $190 at BofA
PremiumThe Fly
Neurocrine price target raised to $199 from $190 at BofA
22d ago
NBIX
SLNO
Balanced Risk-Reward After Soleno Acquisition Supports Neutral Stance on Neurocrine
PremiumRatings
Balanced Risk-Reward After Soleno Acquisition Supports Neutral Stance on Neurocrine
22d ago
NBIX
Neurocrine price target raised to $215 from $192 at H.C. Wainwright
PremiumThe Fly
Neurocrine price target raised to $215 from $192 at H.C. Wainwright
22d ago
NBIX
Neurocrine price target raised to $166 from $151 at Baird
PremiumThe FlyNeurocrine price target raised to $166 from $151 at Baird
22d ago
NBIX
SLNO
Neurocrine price target raised to $242 from $204 at Citi
Premium
The Fly
Neurocrine price target raised to $242 from $204 at Citi
22d ago
NBIX
Neurocrine price target raised to $200 from $164 at Canaccord
Premium
The Fly
Neurocrine price target raised to $200 from $164 at Canaccord
22d ago
NBIX
SLNO
Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull
PremiumRatings
Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull
22d ago
NBIX
Neurocrine price target raised to $220 from $192 at Oppenheimer
PremiumThe Fly
Neurocrine price target raised to $220 from $192 at Oppenheimer
23d ago
NBIX
SLNO
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
PremiumThe Fly
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
23d ago
WW
AMC
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
PremiumRatings
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
23d ago
NBIX
Morning Movers: Soleno pops, Neurocrine dips after acquisition agreement
PremiumThe FlyMorning Movers: Soleno pops, Neurocrine dips after acquisition agreement
23d ago
DOW
LGN
Balanced View on Neurocrine Biosciences: Favorable Soleno Acquisition Prospects Offset by Long-Term Ingrezza and Orphan Market Execution Risks
Premium
Ratings
Balanced View on Neurocrine Biosciences: Favorable Soleno Acquisition Prospects Offset by Long-Term Ingrezza and Orphan Market Execution Risks
23d ago
NBIX
Neurocrine to Acquire Soleno, Expanding Rare Disease Portfolio
Premium
Company Announcements
Neurocrine to Acquire Soleno, Expanding Rare Disease Portfolio
23d ago
8K
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >